These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10806620)

  • 1. Mutation detection in the TGF-beta receptors and smad genes: RT-PCR and sequencing.
    Myeroff LL; He H; Fink SP; Markowitz S
    Methods Mol Biol; 2000; 142():139-47. PubMed ID: 10806620
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutational analysis of TGF-beta type II receptor, Smad2, Smad3, Smad4, Smad6 and Smad7 genes in colorectal cancer.
    Fukushima T; Mashiko M; Takita K; Otake T; Endo Y; Sekikawa K; Takenoshita S
    J Exp Clin Cancer Res; 2003 Jun; 22(2):315-20. PubMed ID: 12866583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
    Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
    Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta signaling is disrupted in endometrioid-type endometrial carcinomas.
    Piestrzeniewicz-Ulanska D; Brys M; Semczuk A; Rechberger T; Jakowicki JA; Krajewska WM
    Gynecol Oncol; 2004 Oct; 95(1):173-80. PubMed ID: 15385128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential gonadotropin treatment of immature mice leads to amplification of transforming growth factor beta action, via upregulation of receptor-type 1, Smad 2 and 4, and downregulation of Smad 6.
    Guéripel X; Benahmed M; Gougeon A
    Biol Reprod; 2004 Mar; 70(3):640-8. PubMed ID: 14585817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between Smad anchor for receptor activation and Smad3 is not essential for TGF-beta/Smad3-mediated signaling.
    Goto D; Nakajima H; Mori Y; Kurasawa K; Kitamura N; Iwamoto I
    Biochem Biophys Res Commun; 2001 Mar; 281(5):1100-5. PubMed ID: 11243848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aberrations of Smad genes in human digestive tract cancers].
    Hagiwara K
    Tanpakushitsu Kakusan Koso; 2001 Feb; 46(2):124-9. PubMed ID: 11211786
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner.
    Verrecchia F; Vindevoghel L; Lechleider RJ; Uitto J; Roberts AB; Mauviel A
    Oncogene; 2001 Jun; 20(26):3332-40. PubMed ID: 11423983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.
    Tian F; Byfield SD; Parks WT; Stuelten CH; Nemani D; Zhang YE; Roberts AB
    Cancer Res; 2004 Jul; 64(13):4523-30. PubMed ID: 15231662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
    Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALK5 and Smad4 are involved in TGF-beta1-induced pulmonary endothelial permeability.
    Birukova AA; Adyshev D; Gorshkov B; Birukov KG; Verin AD
    FEBS Lett; 2005 Jul; 579(18):4031-7. PubMed ID: 16004987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
    Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
    Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor-beta in human umbilical vein endothelial cells.
    Ota T; Fujii M; Sugizaki T; Ishii M; Miyazawa K; Aburatani H; Miyazono K
    J Cell Physiol; 2002 Dec; 193(3):299-318. PubMed ID: 12384983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A catalog of 106 single-nucleotide polymorphisms (SNPs) and 11 other types of variations in genes for transforming growth factor-beta1 (TGF-beta1) and its signaling pathway.
    Watanabe Y; Kinoshita A; Yamada T; Ohta T; Kishino T; Matsumoto N; Ishikawa M; Niikawa N; Yoshiura K
    J Hum Genet; 2002; 47(9):478-83. PubMed ID: 12202987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of the TGF-beta-Smad signaling pathway in pancreatic tumor cells confers resistance to TGF-beta-induced growth arrest.
    Nicolás FJ; Hill CS
    Oncogene; 2003 Jun; 22(24):3698-711. PubMed ID: 12802277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease.
    Monteleone G; Kumberova A; Croft NM; McKenzie C; Steer HW; MacDonald TT
    J Clin Invest; 2001 Aug; 108(4):601-9. PubMed ID: 11518734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.
    Zeisberg M; Hanai J; Sugimoto H; Mammoto T; Charytan D; Strutz F; Kalluri R
    Nat Med; 2003 Jul; 9(7):964-8. PubMed ID: 12808448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis.
    Imai Y; Kurokawa M; Izutsu K; Hangaishi A; Maki K; Ogawa S; Chiba S; Mitani K; Hirai H
    Oncogene; 2001 Jan; 20(1):88-96. PubMed ID: 11244507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling.
    Suh N; Roberts AB; Birkey Reffey S; Miyazono K; Itoh S; ten Dijke P; Heiss EH; Place AE; Risingsong R; Williams CR; Honda T; Gribble GW; Sporn MB
    Cancer Res; 2003 Mar; 63(6):1371-6. PubMed ID: 12649201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.